Testing effectiveness (Phase 2)Study completedNCT02279511What this trial is testingATP in Alzheimer DiseaseWho this might be right forAlzheimer's Disease Sara Varea 20
Not applicableNot Yet RecruitingNCT07047963What this trial is testingNeuropsychological Evaluation in Intellectual Disability (ENDI)Who this might be right forDown Syndrome (Trisomy 21)NeuropsychologyCognitive Aging+2 more Central Hospital, Nancy, France 40
Not applicableStudy completedNCT03382353What this trial is testingEMuNI Project: Multiple Nonpharmacological InterventionsWho this might be right forLifestyle Risk Reduction IRCCS Centro San Giovanni di Dio Fatebenefratelli 120
Not applicableStudy completedNCT01825681What this trial is testingLife Enhancing Activities for Family CaregiversWho this might be right forStressDementiaAffect University of California, San Francisco 175
Not applicableStudy completedNCT02709356What this trial is testingMedium Chain Triglycerides and Brain Metabolism in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Université de Sherbrooke 20
Not applicableEnded earlyNCT01658722What this trial is testingRetrieval of Patient Information After DiscontinuationWho this might be right forAlzheimer's Disease JANSSEN Alzheimer Immunotherapy Research & Development, LLC 169
Testing effectiveness (Phase 2)UnknownNCT01120002What this trial is testingEfficacy and Safety of Tamibarotene (OAM80) for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Osaka City University 50
Not applicableStudy completedNCT00908999What this trial is testingFunctional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)Who this might be right forAnosognosiaAlzheimer's DiseaseMild Cognitive Impairment University of Wisconsin, Madison 60
Not applicableLooking for participantsNCT06584357What this trial is testingDevelopment of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD DementiaWho this might be right forMild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more GAP Innovations, PBC 1,200
Testing effectiveness (Phase 2)WithdrawnNCT04263519What this trial is testingA Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.Who this might be right forAlzheimer DiseaseMild Cognitive Impairment Massachusetts General Hospital
Early research (Phase 1)Study completedNCT00551772What this trial is testingAssess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.Who this might be right forAlzheimer's Disease GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT00480467What this trial is testingStudy Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese MalesWho this might be right forAlzheimer Disease Wyeth is now a wholly owned subsidiary of Pfizer 32
Not applicableStudy completedNCT04856072What this trial is testingDeep Brain Stimulation in Alzheimer's Disease: Biomarkers and Dose OptimizationWho this might be right forAlzheimer Disease University Health Network, Toronto 11
Not applicableStudy completedNCT02409030What this trial is testingMulti-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's DiseaseWho this might be right forAlzheimer Disease Raman Health Technologies, S.L. 700
Not applicableStudy completedNCT03076671What this trial is testingMore Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseWho this might be right forParkinson DiseaseParkinsonismLewy Body Disease+8 more University of Colorado, Denver 783
Post-approval studies (Phase 4)Study completedNCT01122329What this trial is testingA Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's DiseaseWho this might be right forAlzheimer Disease University of California, Los Angeles 17
Testing effectiveness (Phase 2)UnknownNCT05336175What this trial is testingBiomarker Study: Heart Failure Patients at RiskWho this might be right forHeart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IV University of Arizona 40
Not applicableEnrolling By InvitationNCT07234851What this trial is testingUnderstanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.Who this might be right forSchizophrenia DisorderFrontotemporal Dementia, Behavioral VariantMajor Depressive Disorder (MDD)+2 more Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 150
Early research (Phase 1)Study completedNCT01125631What this trial is testingMultiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 8
Very early researchStudy completedNCT03926702What this trial is testingTau Imaging With JNJ067Who this might be right forAlzheimer DiseaseMild Cognitive ImpairmentProgressive Supranuclear Palsy University of California, Berkeley 18